Summarized by Masters of Longevity from Longevity Technology.
A look at a new collaboration between a biotech discovery platform and a cosmetics company aiming to develop omics-informed skin rejuvenation products; learn what this partnership seeks to achieve and why it might matter.
Key Takeaways
- Junevity will use its RESET Platform combining human disease omics and machine learning to identify skin-aging transcription factor targets.
- AmorePacific will lead development and commercialization of cosmetic products based on validated pathways that reset skin gene networks.
- Prior research showed that modulating individual transcription factors can reverse cellular aging hallmarks in human fibroblast models.
